Novel Dihydrooxadiazinones as PDE3 Inhibitors for Treating Cancer
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTNovel Dihydrooxadiazinones as PDE3 Inhibitors for Treating CancerRam W. Sabnis*Ram W. SabnisSmith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States*Email: [email protected]More by Ram W. Sabnishttps://orcid.org/0000-0001-7289-0581Cite this: ACS Med. Chem. Lett. 2021, 12, 7, 1069–1070Publication Date (Web):June 24, 2021Publication History...
Paper Details
Title
Novel Dihydrooxadiazinones as PDE3 Inhibitors for Treating Cancer
Published Date
Jun 24, 2021
Volume
12
Issue
7
Pages
1069 - 1070
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History